área de pesquisa
- A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive -mutant Ovarian Cancer
- Maria Del Pilar Estevez Diz
- Primary results from CECILIA, aglobal single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer